Authors' reply to Laragh and Sealey

Comment

Franz H Messerli et al. BMJ. 2013.

. 2013 Mar 19:346:f1689.

doi: 10.1136/bmj.f1689.

No abstract available

Comment in

Authors' reply to Messerli and colleagues.
Laragh JH, Sealey JE. Laragh JH, et al. BMJ. 2013 Apr 16;346:f2288. doi: 10.1136/bmj.f2288. BMJ. 2013. PMID: 23592467 No abstract available.

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.
Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH. Makani H, et al. BMJ. 2013 Jan 28;346:f360. doi: 10.1136/bmj.f360. BMJ. 2013. PMID: 23358488 Free PMC article.
Sodium depletion in patients in clinical trials may account for the increased cardiovascular risk of dual blockade of the renin-angiotensin system.
Laragh JH, Sealey JE. Laragh JH, et al. BMJ. 2013 Mar 19;346:f1685. doi: 10.1136/bmj.f1685. BMJ. 2013. PMID: 23512453 No abstract available.